DCGen Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $3.64M

  • Investors
  • 7

DCGen General Information

Description

Operator of a multigene assay kit intended for biotechnology management. The company's assay kit offers a breast cancer prognosis prediction kit to analyze breast cancer-specific somatic mutation genes for effective treatment selection, enabling physicians to gain experience in clinical practice and cancer research.

Contact Information

Website
www.dcgen.co.kr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 902, 130, Sajik-ro
  • Seoul, Jongno-gu 03170
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • Room 902, 130, Sajik-ro
  • Seoul, Jongno-gu 03170
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DCGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 19-Dec-2020 $3.64M Completed Generating Revenue
2. Accelerator/Incubator 01-Nov-2018 Completed Generating Revenue
1. Seed Round 30-Sep-2018 Completed Generating Revenue
To view DCGen’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

DCGen Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

DCGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026221175-A1 Composition for predicting prognosis of thyroid cancer Pending 18-Apr-2025
WO-2026182428-A1 Apparatus and method for detecting tumor using pathology slide on basis of artificial intelligence Pending 27-Feb-2025
WO-2026089451-A1 Ngs library quality evaluation system Pending 22-Oct-2024
EP-4814131-A1 Method for cancer prognosis and composition therefor Pending 20-Nov-2023
WO-2025110725-A1 Method for cancer prognosis and composition therefor Inactive 20-Nov-2023 C12Q1/6886
To view DCGen’s complete patent history, request access »

DCGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DCGen Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
InterVest Venture Capital Minority
NCORE Ventures Venture Capital Minority
Premier Partners PE/Buyout Minority
TKG Ventures Venture Capital Minority
Tech Incubator Program for Startup Accelerator/Incubator
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

DCGen FAQs

  • When was DCGen founded?

    DCGen was founded in 2017.

  • Where is DCGen headquartered?

    DCGen is headquartered in Seoul, South Korea.

  • What is the size of DCGen?

    DCGen has 13 total employees.

  • What industry is DCGen in?

    DCGen’s primary industry is Diagnostic Equipment.

  • Is DCGen a private or public company?

    DCGen is a Private company.

  • What is DCGen’s current revenue?

    The current revenue for DCGen is .

  • How much funding has DCGen raised over time?

    DCGen has raised $3.64M.

  • Who are DCGen’s investors?

    InterVest, NCORE Ventures, Premier Partners, TKG Ventures, and Tech Incubator Program for Startup are 5 of 7 investors who have invested in DCGen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process